Expression level of Pre B cell leukemia homeobox 2 correlates with poor prognosis of gastric adenocarcinoma and esophageal squamous cell carcinoma

International Journal of Oncology

Volumn 36, Issue 3, 2010, Pages 651-663

  Qiu, Ying ^a,b   Song, Bogen ^a   Zhao, Guifen ^a   Deng, Biyong ^a   Makino, Tomoki ^b   Tomita, Yasuhiko ^c   Wang, Junchen ^d   Luo, Wenjuan ^e   Doki, Yuichiro ^b   Aozasa, Katsuyuki ^b   Morii, Eiichi ^b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^d Key Laboratory of Arrhythmias of Ministry of Education   (China)

^e MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Esophageal squamous cell carcinoma; Gastric adenocarcinoma; Pre B cell leukemia homeobox; Prognosis

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; MITOMYCIN C; PRE B CELL LEUKEMIA HOMEOBOX 2; PROTEIN BCL 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; ONCOPROTEIN; PBX2 PROTEIN, HUMAN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CANCER GROWTH; CANCER INVASION; CANCER SURGERY; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO SELECTION; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH ADENOCARCINOMA; TOTAL STOMACH RESECTION; BIOSYNTHESIS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; ESOPHAGEAL NEOPLASMS; METABOLISM; MIDDLE AGED; STOMACH NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS; STOMACH NEOPLASMS;

EID: 77149147751     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000541     Document Type: Article

References (40)

1. McGinnis W and Krumlauf R: Homeobox genes and axial patterning. Cell 68: 283-302, 1992.
2. Phelan ML, Rambaldi I and Featherstone MS: Cooperative interactions between Hox and Pbx proteins mediated by a conserved peptide motif. Mol Cell Biol 15: 3989-3997, 1995.
3. Hassan NM, Hamada J, Murai T, et al: Aberrant expression of HOX genes in oral dysplasia and squamous cell carcinoma tissues. Oncol Res 16: 217-224, 2006.
4. Hamada Ji, Omatsu T, Okada F, et al: Overexpression of homeobox gene HOXD3 induces coordinate expression of metastasis-related genes in human lung cancer cells. Int J Cancer 93: 516-525, 2001.
5. Naora H, Yang YQ, Montz FJ, et al: A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells. Proc Natl Acad Sci USA 98: 4060-4065, 2001.
6. Takahashi O, Hamada J, Abe M, et al: Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma. Oncol Rep 17: 753-760, 2007.
7. Rossi Degl'Innocenti D, Castiglione F, Buccoliero AM, et al: Quantitative expression of the homeobox and integrin genes in human gastric carcinoma. Int J Mol Med 20: 621-629, 2007.
8. Shimoda M, Takahashi M, Yoshimoto T, et al: A homeobox protein, prox1, is involved in the differentiation, proliferation, and prognosis in hepatocellular carcinoma. Clin Cancer Res 12: 6005-6011, 2006.
9. Miller GJ, Miller HL, van Bokhoven A, et al: Aberrant HOXC expression accompanies the malignant phenotype in human prostate. Cancer Res 63: 5879-5888, 2003.
10. Cantile M, Cindolo L, Napodano G, et al: Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas. Oncogene 22: 6462-6468, 2003.
11. Li H, Huang CJ and Choo KB: Expression of homeobox genes in cervical cancer. Gynecol Oncol 84: 216-221, 2002.
12. Rozovskaia T, Feinstein E, Mor O, et al: Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4:11) abnormality. Oncogene 20: 874-878, 2001.
13. Eklund EA: The role of HOX genes in malignant myeloid disease. Curr Opin Hematol 14: 85-89, 2007.
14. Golub TR, Slonim DK, Tamayo P, et al: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537, 1999.
15. Plowright L, Harrington KJ, Pandha HS, et al: HOX transcription factors are potential therapeutic targets in non-smallcell lung cancer (targeting HOX genes in lung cancer). Br J Cancer 100: 470-475, 2009.
16. Nakamura T, Jenkins NA and Copeland NG: Identification of a new family of Pbx-related homeobox genes. Oncogene 13: 2235-2242, 1996.
17. Aulisa L, Forraz N, McGuckin C, et al: Inhibition of cancer cell proliferation by designed peptide amphiphiles. Acta Biomater 5: 842-853, 2009.
18. Kamangar F, Dores GM and Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150, 2006.
19. Enzinger PC and Mayer RJ: Esophageal cancer. N Engl J Med 349: 2241-2252, 2003.
20. Daly JM, Fry WA, Little AG, et al: Esophageal cancer: results of an American College of Surgeons patient care evaluation study. J Am Coll Surg 190: 562-572, 2000.
21. Buskens CJ, Ten Kate FJ, Obertop H, et al: Analysis of micrometastatic disease in histologically negative lymph nodes of patients with adenocarcinoma of the distal esophagus or gastric cardia. Dis Esophagus 21: 488-495, 2007.
22. Lambert R, Guilloux A, Oshima A, et al: Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer 97: 811-818, 2002.
23. Roder JD, Stein HJ, Böttcher K, et al: Surgical therapy for gastric cancer. J Infus Chemother 5: 97-103, 1995.
24. Qiu Y, Morii E, Tomita Y, et al: Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non-small cell lung carcinoma. Cancer Sci (In press).
25. Sobin LH and Wittekind CH: TNM classification of malignant tumours. 6th edition, Wiley-Liss, New York, 2002.
26. Qiu Y, Tomita Y, Zhang B, et al: Pre-B-cell leukemia transcription factor 1 regulates expression of valosin-containing protein, a gene involved in cancer growth. Am J Pathol 170: 152-159, 2007.
27. Meyer-Siegler KL, Iczknowski KA, Leng L, et al: Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J Immunol 177: 8730-8739, 2006.
28. Nozoe T, Saeki H, Ohga T, et al: Clinicopathological features of early esophageal squamous cell carcinoma with subsequent recurrence. Dis Esophagus 15: 145-148, 2002.
29. Dawsey SM, Wang GQ, Weinstein WM, et al: Squamous dysplasia and early esophageal cancer in the Linxian region of China: distinctive endoscopic lesions. Gastroenterology 105: 1333-1340, 1993.
30. Eloubeidi MA, Desmond R, Arguedas MR, et al: Prognostic factors for the survival of patients with esophageal carcinoma in the US: the importance of tumor length and lymph node status. Cancer 95: 1434-1443, 2002.
31. Liu C, Zhang R, Lu Y, et al: Prognostic role of lymphatic vessel invasion in early gastric cancer: A retrospective study of 188 cases. Surg Oncol (In press).
32. Vazquez-Sequeiros E, Wang L, Burgart L, et al: Occult lymph node metastases as a predictor of tumor relapse in patients with node-negative esophageal carcinoma. Gastroenterology 122: 1815-1821, 2002.
33. Longobardi E and Blasi F: Overexpression of PREP-1 in F9 teratocarcinoma cells leads to a functionally relevant increase of PBX-2 by preventing its degradation. J Biol Chem 278: 39235-39241, 2003.
34. Laurent A, Bihan R, Omilli F, et al: PBX proteins: much more than Hox cofactors. Int J Dev Biol 52: 9-20, 2008.
35. Van Dijk MA, Peltenburg LT and Murre C: Hox gene products modulate the DNA binding activity of Pbx1 and Pbx2. Mech Dev 52: 99-108, 1995.
36. Strathdee G, Holyoake TL, Sim A, et al: Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis. Clin Cancer Res 13: 5048-5055, 2007.
37. Argiropoulos B and Humphries RK: Hox genes in hematopoiesis and leukemogenesis. Oncogene 26: 6766-6776, 2007.
38. Juan M, Minhu C, Jide W, et al: Pancreatic duodenal homeobox-1 (PDX1) functions as a tumor suppressor in gastric cancer. Carcinogenesis 29: 1327-1333, 2008.
39. Potts MB, Wang DP and Cameron S: Trithorax, Hox, and TALEclass homeodomain proteins ensure cell survival through repression of the BH3-only gene egl-1. Dev Biol 329: 374-385, 2009.
40. Shears L, Plowright L, Harrington K, et al: Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P. J Urol 180: 2196-2201, 2008.